<?xml version="1.0" encoding="UTF-8"?>
<results title="tropicalVirus">
 <result pre="in important chapters of both, World and Brazilian epidemiology histories." exact="Yellow fever" post="virus (YFV), Dengue virus (DENV) and Zika virus (ZIKV)"/>
 <result pre="both, World and Brazilian epidemiology histories. Yellow fever virus (YFV)," exact="Dengue" post="virus (DENV) and Zika virus (ZIKV) were sequentially imported"/>
 <result pre="epidemiology histories. Yellow fever virus (YFV), Dengue virus (DENV) and" exact="Zika" post="virus (ZIKV) were sequentially imported to Brazil and South"/>
 <result pre="urban areas (2). In 1981, the first epidemic caused by" exact="DENV" post="was confirmed in Brazil (3). Since then, many epidemics"/>
 <result pre="annually by one of its four serotypes (DENV1-4) (5). Thus," exact="DENV" post="is considered as the flavivirus of highest epidemiologic relevance"/>
 <result pre="flavivirus of highest epidemiologic relevance of the world. But recently," exact="ZIKV" post="which was a pathogen previously associated with mild infections"/>
 <result pre="Guillain-Barré syndrome in the Americas (6). The first cases of" exact="ZIKV" post="infection were reported in early 2015, in the Brazilian"/>
 <result pre="worldwide epidemiological importance or which are highly pathogenic. Examples are" exact="West Nile" post="virus (WNV), Japanese encephalitis virus (JEV), Saint Louis encephalitis"/>
 <result pre="as antibody-dependent enhancement (ADE), is observed in some cases of" exact="DENV" post="infection. Immunoglobulins produced in a first infection by a"/>
 <result pre="cells by non-neutralizing antibodies, which facilitates penetration and replication of" exact="DENV" post="(1, 11). Increased viral replication leads to increased viral"/>
 <result pre="cytokine storm (11, 12). ADE has also been described between" exact="DENV" post="and ZIKV in vitro (8, 13–15). This phenomenon does"/>
 <result pre="(11, 12). ADE has also been described between DENV and" exact="ZIKV" post="in vitro (8, 13–15). This phenomenon does not explain"/>
 <result pre="were those of highest epidemiological relevance in Brazil and worldwide:" exact="Dengue" post="virus (DENV), Zika virus (ZIKV), Yellow fever virus (YFV),"/>
 <result pre="highest epidemiological relevance in Brazil and worldwide: Dengue virus (DENV)," exact="Zika" post="virus (ZIKV), Yellow fever virus (YFV), West Nile virus"/>
 <result pre="in Brazil and worldwide: Dengue virus (DENV), Zika virus (ZIKV)," exact="Yellow fever" post="virus (YFV), West Nile virus (WNV), Japanese encephalitis virus"/>
 <result pre="Dengue virus (DENV), Zika virus (ZIKV), Yellow fever virus (YFV)," exact="West Nile" post="virus (WNV), Japanese encephalitis virus (JEV), Saint Louis encephalitis"/>
 <result pre="were: CD4+ T cell, CD8+ T cell, epitopes, protection, immunity," exact="Dengue" post="virus, Zika virus, Yellow Fever virus, West Nile virus,"/>
 <result pre="T cell, CD8+ T cell, epitopes, protection, immunity, Dengue virus," exact="Zika" post="virus, Yellow Fever virus, West Nile virus, Japanese encephalitis"/>
 <result pre="epitopes, protection, immunity, Dengue virus, Zika virus, Yellow Fever virus," exact="West Nile" post="virus, Japanese encephalitis virus, Saint Louis encephalitis virus, Rocio"/>
 <result pre="Virusb Epitope sequence/location Conservancy (≥90%) 100% identityc Protein location 110534" exact="WNV" post="W101, G104, G106 99.67% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
 <result pre="W101, G104, G106 99.67% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 161539 DENV W101, G106, L107, F108 99.34%"/>
 <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 161539" exact="DENV" post="W101, G106, L107, F108 99.34% DENV1, DENV2, DENV3, DENV4,"/>
 <result pre="G106, L107, F108 99.34% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 178102 DENV W101, L107,G109 99.67% DENV1, DENV2,"/>
 <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 178102" exact="DENV" post="W101, L107,G109 99.67% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV,"/>
 <result pre="DENV W101, L107,G109 99.67% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 191061 DENV T76, W101, G106, L107, F108"/>
 <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 191061" exact="DENV" post="T76, W101, G106, L107, F108 90.43% DENV1, DENV2, DENV3,"/>
 <result pre="W101, G106, L107, F108 90.43% DENV1, DENV2, DENV3, DENV4, ZIKV," exact="WNV" post="E protein 191066 DENV W101, G106, F108 99.67% DENV1,"/>
 <result pre="90.43% DENV1, DENV2, DENV3, DENV4, ZIKV, WNV E protein 191066" exact="DENV" post="W101, G106, F108 99.67% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
 <result pre="W101, G106, F108 99.67% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 191060 DENV T76, L107, F108 90.76% DENV1,"/>
 <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 191060" exact="DENV" post="T76, L107, F108 90.76% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
 <result pre="DENV T76, L107, F108 90.76% DENV1, DENV2, DENV3, DENV4, ZIKV," exact="WNV" post="E protein 191068 DENV W101, L107, F108 99.67% DENV1,"/>
 <result pre="90.76% DENV1, DENV2, DENV3, DENV4, ZIKV, WNV E protein 191068" exact="DENV" post="W101, L107, F108 99.67% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
 <result pre="W101, L107, F108 99.67% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 191062 DENV T76, W101, L107, F108 90.76%"/>
 <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 191062" exact="DENV" post="T76, W101, L107, F108 90.76% DENV1, DENV2, DENV3, DENV4,"/>
 <result pre="T76, W101, L107, F108 90.76% DENV1, DENV2, DENV3, DENV4, ZIKV," exact="WNV" post="E protein 191057 DENV G78, W101, L107, F108 99.67%"/>
 <result pre="90.76% DENV1, DENV2, DENV3, DENV4, ZIKV, WNV E protein 191057" exact="DENV" post="G78, W101, L107, F108 99.67% DENV1, DENV2, DENV3, DENV4,"/>
 <result pre="W101, L107, F108 99.67% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 238073 DENV R99, G102, G106, L107 99.34%"/>
 <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 238073" exact="DENV" post="R99, G102, G106, L107 99.34% DENV1, DENV2, DENV3, DENV4,"/>
 <result pre="G102, G106, L107 99.34% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 504083 DENV R73, G78, E79 91.42% DENV1,"/>
 <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 504083" exact="DENV" post="R73, G78, E79 91.42% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
 <result pre="DENV R73, G78, E79 91.42% DENV1, DENV2, DENV3, DENV4, ZIKV," exact="WNV" post="E protein 161528 DENV K307, K310, L389 100.00% DENV1,"/>
 <result pre="91.42% DENV1, DENV2, DENV3, DENV4, ZIKV, WNV E protein 161528" exact="DENV" post="K307, K310, L389 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
 <result pre="K307, K310, L389 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 161534 DENV T303, T329, G383 100.00% DENV1,"/>
 <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 161534" exact="DENV" post="T303, T329, G383 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
 <result pre="T303, T329, G383 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 191056 DENV G78, W101, F108 100.00% DENV1,"/>
 <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 191056" exact="DENV" post="G78, W101, F108 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
 <result pre="G78, W101, F108 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 504090 DENV W101, L107, G111 100.00% DENV1,"/>
 <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 504090" exact="DENV" post="W101, L107, G111 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
 <result pre="W101, L107, G111 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 504074 DENV N103, G104, G111 100.00% DENV1,"/>
 <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 504074" exact="DENV" post="N103, G104, G111 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
 <result pre="N103, G104, G111 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 504080 DENV G100, W101, F108 100.00% DENV1,"/>
 <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 504080" exact="DENV" post="G100, W101, F108 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
 <result pre="G100, W101, F108 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein 530626 DENV D378, R379, W381 100.00% DENV1,"/>
 <result pre="DENV1, DENV2, DENV3, DENV4, ZIKV, YFV, WNV E protein 530626" exact="DENV" post="D378, R379, W381 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV,"/>
 <result pre="D378, R379, W381 100.00% DENV1, DENV2, DENV3, DENV4, ZIKV, YFV," exact="WNV" post="E protein aNumber of epitope ID at IEDB website."/>
 <result pre="of highly conserved neutralizing epitopes in flaviviruses. (A) Model of" exact="DENV" post="envelope glycoprotein arranged as a dimer [(33), PDB number"/>
 <result pre="of selected epitopes into species-specific polyprotein datasets. Epitopes sequences DENV1" exact="DENV" post="2 DENV3 DENV4 ZIKV YFV WNV SLEV JEV IGUV"/>
 <result pre="species-specific polyprotein datasets. Epitopes sequences DENV1 DENV 2 DENV3 DENV4" exact="ZIKV" post="YFV WNV SLEV JEV IGUV ILHV ROCV APTRVVAAEMa,b 90%"/>
 <result pre="polyprotein datasets. Epitopes sequences DENV1 DENV 2 DENV3 DENV4 ZIKV" exact="YFV" post="WNV SLEV JEV IGUV ILHV ROCV APTRVVAAEMa,b 90% 100%"/>
 <result pre="datasets. Epitopes sequences DENV1 DENV 2 DENV3 DENV4 ZIKV YFV" exact="WNV" post="SLEV JEV IGUV ILHV ROCV APTRVVAAEMa,b 90% 100% 100%"/>
 <result pre="The locations of epitopes are shown in two different models:" exact="DENV" post="NS3 protein (A,B) and ZIKV NS5 protein (C,D). (A)"/>
 <result pre="shown in two different models: DENV NS3 protein (A,B) and" exact="ZIKV" post="NS5 protein (C,D). (A) The helicase domain of the"/>
 <result pre="ZIKV NS5 protein (C,D). (A) The helicase domain of the" exact="DENV" post="NS3 protein is shown in olive, while its protease"/>
 <result pre="alanine prevents membrane fusion (56). In addition, natural infection by" exact="DENV" post="was hypothesized to generate anti-DENV antibodies with cross-neutralizing activity"/>
 <result pre="selected B cell epitopes were show to be important in" exact="DENV" post="neutralization (57, 61–63). Of course, a physic validation regarding"/>
 <result pre="This is in accordance with the highest genetic distance of" exact="YFV" post="serocomplex with regard to other flavivirus serocomplexes (23). An"/>
 <result pre="flaviviruses may arise from this observation. For example, vaccination against" exact="YFV" post="in Brazil is not currently related to protection against"/>
 <result pre="YFV in Brazil is not currently related to protection against" exact="DENV" post="and ZIKV epidemics. However, DENV and JEV serocomplexes share"/>
 <result pre="Brazil is not currently related to protection against DENV and" exact="ZIKV" post="epidemics. However, DENV and JEV serocomplexes share most of"/>
 <result pre="currently related to protection against DENV and ZIKV epidemics. However," exact="DENV" post="and JEV serocomplexes share most of epitopes identified in"/>
 <result pre="of epitopes identified in this work. It seems immunity to" exact="DENV" post="precludes viruses of JEV serocomplex of circulating in South"/>
 <result pre="South America. Recent studies showed evidences of cross-protective immunity between" exact="DENV" post="and JEV serocomplexes (23, 54). The same does not"/>
 <result pre="by the set of epitopes, but there is co-circulation of" exact="DENV" post="and JEV serocomplexes in that country. In addition, most"/>
 <result pre="population coverage of our set of epitopes, present co-circulation of" exact="DENV" post="and JEV serocomplexes. The explanation for this is probably"/>
 <result pre="CD8+ T limphocytes capable of producing IFN-γ and TNF-α against" exact="DENV" post="infection (24, 27). In addition, the peptide APTRVVAAEM is"/>
 <result pre="In addition, the peptide APTRVVAAEM is involved in cross-protection against" exact="DENV" post="and ZIKV. The epitopes TDTTPFGQQRVFKEK, EFGKAKGSRAIWYMW, and AKGSRAIWYMWLGAR are"/>
 <result pre="which are involved in elicitation of protective immune memory against" exact="YFV" post="(40). The epitope MTTEDMLQVW is involved in protection against"/>
 <result pre="currently approved for use in humans is a chimera between" exact="DENV" post="and YFV. Its structural antigens are representative of DENV"/>
 <result pre="between DENV and YFV. Its structural antigens are representative of" exact="DENV" post="proteins, while non-structural antigens are representative of YFV proteins."/>
 <result pre="representative of DENV proteins, while non-structural antigens are representative of" exact="YFV" post="proteins. In addition, the JEV vaccine is based on"/>
 <result pre="http://www.cdc.gov/zika/geo/ (accessed March 15, 2016). 7.de BritoCAACordeiroMTOne year after the" exact="Zika" post="virus outbreak in Brazil: from hypotheses to evidence. Rev"/>
 <result pre="antibody responses after dengue virus infection are highly cross-reactive to" exact="Zika" post="virus. Proc Natl Acad Sci USA. (2016) 113:7852–7. 10.1073/pnas.160793111327354515"/>
 <result pre="virus. Proc Natl Acad Sci USA. (2016) 113:7852–7. 10.1073/pnas.160793111327354515 9.WikanNSmithDR." exact="Zika" post="virus: history of a newly emerging arbovirus. Lancet Infect"/>
 <result pre="Lancet Infect Dis. (2016) 16:e119–26. 10.1016/S1473-3099(16)30010-X27282424 10.De MelloMRezendeDAdelinoRAlvesACamposFIaniDMet al.Persistence of" exact="Yellow fever" post="virus outside the Amazon Basin, causing epidemics in Southeast"/>
 <result pre="10.1038/nri301421760609 13.CastanhaPMNascimentoEJMCynthiaBCordeiroMTde CarvalhoOVdeMendonça LRet al.Dengue virus (DENV)-specific antibodies enhance Brazilian" exact="Zika" post="virus (ZIKV) infection. J Infect Dis. (2016) 215:781–5. 10.1093/infdis/jiw638"/>
 <result pre="(ZIKV) infection. J Infect Dis. (2016) 215:781–5. 10.1093/infdis/jiw638 14.DejnirattisaiWSupasaPWongwiwatWRouvinskiABarba-SpaethGDuangchindaTet al.." exact="Dengue" post="virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika"/>
 <result pre="with zika virus. Nat Immunol. (2016) 17:1102–8. 10.1038/ni.351527339099 15.PaulLMCarlinERJenkinsMMTanALBarcellonaCMNicholsonCOet al.." exact="Dengue" post="virus antibodies enhance Zika virus infection. Clin Transl Immunol."/>
 <result pre="Immunol. (2016) 17:1102–8. 10.1038/ni.351527339099 15.PaulLMCarlinERJenkinsMMTanALBarcellonaCMNicholsonCOet al.. Dengue virus antibodies enhance" exact="Zika" post="virus infection. Clin Transl Immunol. (2016) 5:e117. 10.1038/cti.2016.7228090318 16.MansfieldKLHortonDLJohnsonNLiLBarrettADTSmithDJet"/>
 <result pre="cells. Sci Adv. (2018) 4:eaar4297. 10.1126/sciadv.aar429729978039 24.WenJTangWWSheetsNEllisonJSetteAKimKet al.. Identification of" exact="Zika" post="virus epitopes reveals immunodominant and protective roles for dengue"/>
 <result pre="Microbiol. (2017) 2:17036. 10.1038/nmicrobiol.2017.3628288094 25.ReynoldsCJSuleymanOMOrtega-PrietoAMSkeltonJKBonnesoeurPBlohmAet al.. T cell immunity to" exact="Zika" post="virus targets immunodominant epitopes that show cross-reactivity with other"/>
 <result pre="Flaviviruses. Sci Rep. (2018) 8:672. 10.1038/s41598-017-18781-129330423 26.Regla-NavaJAElong NgonoAViramontesKMHuynhATWangYTNguyenAVTet al.. Cross-reactive" exact="Dengue" post="virus-specific CD8+ T cells protect against Zika virus during"/>
 <result pre="NgonoAViramontesKMHuynhATWangYTNguyenAVTet al.. Cross-reactive Dengue virus-specific CD8+ T cells protect against" exact="Zika" post="virus during pregnancy. Nat Commun. (2018) 9:3042. 10.1038/s41467-018-05458-030072692 27.WeiskopfDAngeloMABangsDJSidneyJPaulSPetersBet"/>
 <result pre="epitopes. J Virol. (2015) 89:120–8. 10.1128/JVI.02129-1425320311 28.WeiskopfDBangsDJSidneyJKollaRVDe SilvaADde SilvaAMet al.." exact="Dengue" post="virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T"/>
 <result pre="10.1186/1471-2105-8-36117897458 35.dos Santos FrancoLOliveira VidalPAmorimJH. In silico design of a" exact="Zika" post="virus non-structural protein 5 aiming vaccine protection against zika"/>
 <result pre="10.4049/jimmunol.130150724058176 42.DuanZLLiuHFHuangXWangSNYangJLChenXYet al.. Identification of conserved and HLA-A*2402-restricted epitopes in" exact="Dengue" post="virus serotype 2. Virus Res. (2015) 196:5–12. 10.1016/j.virusres.2014.10.02225449574 43.TurtleLBaliTBuxtonGChibSChanSSoniMet"/>
 <result pre="Cross-protection induced by Japanese encephalitis vaccines against different genotypes of" exact="Dengue" post="viruses in mice. Sci Rep. (2016) 6:19953. 10.1038/srep1995326818736 55.CockburnJJBNavarro"/>
 <result pre="cells. J Virol. (2001) 75:7769–73. 10.1128/JVI.75.16.7769-7773.200111462053 60.NybakkenGEOliphantTJohnsonSBurkeSDiamondMSFremontDH. Structural basis of" exact="West Nile" post="virus neutralization by a therapeutic antibody. Nature. (2005) 437:764–9."/>
 <result pre="MAbs. (2016) 8:574–84. 10.1080/19420862.2016.114885026905804 64.LiS-HLiX-FZhaoHJiangTDengY-QYuX-Det al.. Cross protection against lethal" exact="West Nile" post="virus challenge in mice immunized with recombinant E protein"/>
 <result pre="138:156–60. 10.1016/j.imlet.2011.04.00321515306 65.ChowdhuryPKhanSAChowdhuryPBorahJDuttaPCross-protective immunity against circulating Japanese encephalitis virus and" exact="West Nile" post="Virus by live attenuated Japanese encephalitis vaccine SA 14-14-2."/>
</results>
